Literature DB >> 23253438

Magnetic resonance contrast and biological effects of intracellular superparamagnetic iron oxides on human mesenchymal stem cells with long-term culture and hypoxic exposure.

Jens T Rosenberg1, Katelyn L Sellgren, Afi Sachi-Kocher, Fabian Calixto Bejarano, Michelle A Baird, Michael W Davidson, Teng Ma, Samuel C Grant.   

Abstract

BACKGROUND AIMS: Human mesenchymal stem cells (hMSCs) have gained interest for treatment of stroke injury. Using in vitro culture, the purpose of this study was to investigate the long-term detectability of hMSCs by magnetic resonance imaging (MRI) after transfection with a superparamagnetic iron oxide (SPIO) and evaluate the effects of SPIO on cellular activity, particularly under an ischemic environment.
METHODS: hMSCs were exposed to low doses of SPIOs. After a short incubation period, cells were cultured for additional 1, 7 and 14 d to evaluate proliferation, colony formation and multilinear potential. Labeled cells were imaged and evaluated in agarose to quantify R2 and R2∗ contrast at each time point. Cells were placed in a low-oxygen, low-serum environment and tested for cytotoxicity. In addition, labeled cells were transplanted into an ischemic stroke model and evaluated with ex vivo MRI and histology.
RESULTS: Cellular events such as proliferation and differentiation were not affected at any of the exposures tested when cultured for 14 d. The low iron exposure and short incubation time are sufficient for detectability with MRI. However, the higher iron dosage results in higher calcification and cytotoxicity under in vitro ischemic conditions. Transplantation of the hMSCs labeled with an initial exposure of 22.4 μg of Fe showed excellent retention of contrast in stroke-induced rats.
CONCLUSIONS: Although SPIO labeling is stable for long-term MRI detection and has limited effects on the multilineage potential of hMSCs, high-dose SPIO labeling may affect hMSC survival under serum and oxygen withdrawal.
Copyright © 2013 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23253438     DOI: 10.1016/j.jcyt.2012.10.013

Source DB:  PubMed          Journal:  Cytotherapy        ISSN: 1465-3249            Impact factor:   5.414


  12 in total

1.  Experimental study of super paramagnetic iron oxide labeled synovial mesenchymal stem cells.

Authors:  Fang-Yuan Yu; Hong-Hang Li; Chang-Hui Chen; Sheng-Rong Bi
Journal:  Int J Clin Exp Med       Date:  2015-11-15

2.  Rhodamine bound maghemite as a long-term dual imaging nanoprobe of adipose tissue-derived mesenchymal stromal cells.

Authors:  Vratislav Cmiel; Josef Skopalik; Katerina Polakova; Jan Solar; Marketa Havrdova; David Milde; Ivan Justan; Massimiliano Magro; Zenon Starcuk; Ivo Provaznik
Journal:  Eur Biophys J       Date:  2016-11-26       Impact factor: 1.733

Review 3.  Genetic engineered molecular imaging probes for applications in cell therapy: emphasis on MRI approach.

Authors:  In K Cho; Silun Wang; Hui Mao; Anthony Ws Chan
Journal:  Am J Nucl Med Mol Imaging       Date:  2016-09-22

4.  Aggregation of human mesenchymal stem cells enhances survival and efficacy in stroke treatment.

Authors:  Xuegang Yuan; Jens T Rosenberg; Yijun Liu; Samuel C Grant; Teng Ma
Journal:  Cytotherapy       Date:  2019-09-17       Impact factor: 5.414

5.  Impacts of fluorescent superparamagnetic iron oxide (SPIO)-labeled materials on biological characteristics and osteogenesis of bone marrow mesenchymal stem cells (BMSCs).

Authors:  Guangping Zhang; Zhenwen Na; Bin Ren; Xin Zhao; Weixian Liu
Journal:  Int J Clin Exp Med       Date:  2015-08-15

6.  Olfactory bulb-targeted quantum dot (QD) bioconjugate and Kv1.3 blocking peptide improve metabolic health in obese male mice.

Authors:  Austin B Schwartz; Anshika Kapur; Zhenbo Huang; Raveendra Anangi; John M Spear; Scott Stagg; Erminia Fardone; Zolan Dekan; Jens T Rosenberg; Samuel C Grant; Glenn F King; Hedi Mattoussi; Debra Ann Fadool
Journal:  J Neurochem       Date:  2020-10-20       Impact factor: 5.372

7.  Multiparametric classification of sub-acute ischemic stroke recovery with ultrafast diffusion, 23 Na, and MPIO-labeled stem cell MRI at 21.1 T.

Authors:  Avigdor Leftin; Jens T Rosenberg; Xuegang Yuan; Teng Ma; Samuel C Grant; Lucio Frydman
Journal:  NMR Biomed       Date:  2019-12-03       Impact factor: 4.044

8.  Localization of human mesenchymal stem cells from umbilical cord blood and their role in repair of diabetic foot ulcers in rats.

Authors:  Qing-Song Zhao; Nan Xia; Nan Zhao; Ming Li; Chang-Long Bi; Qing Zhu; Guo-Fen Qiao; Zhi-Feng Cheng
Journal:  Int J Biol Sci       Date:  2013-12-19       Impact factor: 6.580

9.  Tracking of mesenchymal stem cells labeled with gadolinium diethylenetriamine pentaacetic acid by 7T magnetic resonance imaging in a model of cerebral ischemia.

Authors:  Kuan Geng; Zhong Xian Yang; Dexiao Huang; Meizi Yi; Yanlong Jia; Gen Yan; Xiaofang Cheng; Renhua Wu
Journal:  Mol Med Rep       Date:  2014-10-29       Impact factor: 2.952

10.  NODDI highlights recovery mechanisms in white and gray matter in ischemic stroke following human stem cell treatment.

Authors:  F Andrew Bagdasarian; Xuegang Yuan; Jacob Athey; Bruce A Bunnell; Samuel C Grant
Journal:  Magn Reson Med       Date:  2021-08-06       Impact factor: 3.737

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.